The work reveals the structural features of antagonist-bound CB2 and the unique ligand binding mode, which will facilitate rational drug design toward precise modulation of the endocannabinoid system. These new findings are published in the prestigious journal Cell, titled “Crystal structure of the Human Cannabinoid Receptor CB2”.